Skip to main content

Table 3 The HA production by the recombinant B. subtilis strains

From: The effect of manipulating glucuronic acid biosynthetic pathway in Bacillus subtilis strain on hyaluronic acid production

Recombinant strain

Clone No

STD

RSD (%)

HA titer (mg/ml)

RBSHA

C1

0.11

5.87

0.08

C2

0.10

5.95

0.32

C3

0.01

0.74

0.18

C4

0.09

5.99

0.23

C5

0.16

7.06

0.21

C6

0.14

5.94

0.55

C7

0.11

6.00

0.35

RBSHA2

C2g1

0.18

9.72

1.57

C2g 2

0.10

5.63

1.44

C2g 3

0.03

1.32

1.90

C2g 4

0.17

9.76

1.46

C2g 5

0.10

5.19

1.41

C2g 6

0.07

3.69

1.29

C2g 7

0.17

8.87

1.21

C2g 8

0.17

9.76

1.46

C2g 9

0.10

5.19

1.41

RBSHA3

C3g 1

0.18

8.36

2.06

C3g 2

0.19

9.49

1.37

C3g 3

0.04

2.06

1.66

C3g 4

0.20

9.35

1.52

C3g 5

0.07

3.22

1.81

C3g 6

0.17

8.22

1.43

C3g 7

0.11

4.63

2.02

C3g 8

0.04

2.06

1.66

Strains

HA titer range (mg/ml)

RBSHA

0.08–0.55

RBSHA2

1.21–1.90

RBSHA3

1.37–2.06